Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CAMBRIDGE, Mass. & BRISBANE, Australia (BUSINESS WIRE) Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced positive interim results from a